PubMed Health⌕ Search

Biomedical subjects

C G Scanes

Publications and source records attributed to C G Scanes.

At least 37 records · Page 2Linked to original sources
PubMed1997

Ontogeny of insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in the chicken following hatching.

The present study examined plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding proteins (IGFBPs) during posthatch growth and development in chickens. Three distinct proteins which bound 125I-IGF-I were observed irrespective of age or sex, these having apparent molecular weights of 22, 28, and 36 kDa. The major IGFBP present during much of the growth and development period was the 28-kDa form followed by the 36-kDa form. Plasma concentrations of IGF-II and of the 22-kDa IGFBP showed little ontogenic variation with the exception of elevated levels of the 22 kDa IGFBP in 1-day-old chicks. The circulating concentrations of IGF-I and of the 28-kDa IGFBP increased progressively between the time of hatching to reach a maximum at 6 weeks of age and subsequently declined to lower levels in adults. Somewhat similarly, the 36-kDa IGFBP increased during early pre- and posthatching growth to a maximum at 6 weeks of age. There were marked sex differences in circulating concentrations of IGF-I in young (4 week) and adult chickens and in the 36-kDa IGFBP in the adult, both being lower in females. Estrogen treatment of adult male chickens decreased the circulating concentrations of IGF-I together with the level of both the 28- and 36-kDa IGFBPs. Testosterone treatment had no effect on the circulating concentrations of either IGF-I or IGFBPs in adult female chickens. We conclude that the relative levels of IGF-I, IGF-II, and the IGFBPs change with age. In addition, circulating concentrations of estrogen may play a role in the regulation of IGF-I and IGFBPs.

Aging↗
PubMed1997

The thyroid hormone, 3,5,3'-triiodothyronine, is a negative modulator of domestic fowl (Gallus gallus domesticus) adrenal steroidogenic function.

Previous work with chickens (Gallus gallus domesticus) suggests a relationship between depressed thyroid hormone status and enhanced adrenal steroidogenic function. In addition, in hypophysectomized chickens, replacement of the thyroid hormone, 3,5,3'-triiodothyronine (T3), maintains chicken adrenal steroidogenic cell sensitivity to adrenocorticotropin (ACTH) but decreases steroidogenic capacity further than that due to hypophysectomy alone. The present in vivo and in vitro studies were conducted to determine the influence of thyroid status and T3 per se on avian adrenal steroidogenic function. Chicks (1 day old) were thyroidectomized using combined surgical and chemical (6-propyl-2-thiouracil) treatments and were administered a replacement dose of T3 (0, 1.5, 4.5, 15, and 45 microg/kg body wt/day) for 5 weeks. Whereas thyroidectomy (TX) decreased adrenal weight (-20%), it increased relative adrenal weight (mg/100 g body weight) (+171%), trunk plasma corticosterone (+880%), and aldosterone (+124%). In addition, TX increased basal, maximal ACTH-induced, maximal 8-bromo-cyclic AMP-induced, and maximal 25-hydroxycholesterol-supported corticosterone production (+520, +93, +124, and +195%, respectively) and aldosterone production (+578, +288, +280, and +275%, respectively) by isolated adrenal steroidogenic cells. T3, in a dose-dependent manner, reversed the effects of TX on these in vivo and in vitro parameters of adrenal steroidogenic function. Restoration of most of these parameters to those in the sham-treated control was attained with 4.5-15 microg/kg body wt/day. Although some of the effects of TX and T3 replacement on adrenal steroidogenic function may have been mediated through changes in circulating levels of ACTH, other data suggest a direct effect on adrenal steroidogenic cell function. Adrenal steroidogenic cells from sham-treated and TX birds were preincubated (0, 4, and 12 hr) with various concentrations of T3 (0, 0.3, 3, and 30 nM), washed, and then incubated for an additional 2 hr in medium containing the same respective concentrations of T3, with or without a maximal steroidogenic concentration of ACTH (100 nM). T3 had no acute effects on TX-dependent enhancement of adrenal steroidogenic cell function (2-hr incubation). However, with preincubation (4 and 12 hr), T3 inhibited basal and maximal ACTH-induced corticosterone production in a dose-dependent manner. This concentration-dependent, direct effect of T3 was not observed with cells from sham-treated birds. In addition, the ostensibly inactive thyroid hormone metabolite, 3,3',5'-triiodothyronine [reverse T3; 30 nM], was without effect. Taken collectively, these studies indicate that T3 is a direct negative modulator of avian adrenal steroidogenic function.

Adrenal Cortex Hormones↗
PubMed1997

Quantitative studies of chicken somatotrophs during growth and development by morphometry, immunocytochemistry, and flow cytometry.

Changes in the male chicken somatotroph during growth and maturation have been examined by morphometric and immunocytochemical (ICC) analysis of serial sections of the anterior pituitary gland and by flow cytometry of dispersed anterior pituitary cells. ICC showed that somatotrophs are confined to the middle and caudal thirds of the anterior pituitary gland at all ages from 5 to 26 weeks. At a given age somatotrophs are of equal size at all positions along the cephalocaudal axis of the anterior pituitary gland. However, there are age-related changes: from 5 to 11 weeks rises occur in both the mean total somatotroph volume per gland (64%) and the mean number of somatotrophs (78%), while the mean volume of the single somatotroph is unchanged. From 11 to 18 weeks the mean volume of the single somatotroph decreases 41%. From 18 to 26 weeks the mean volume of the somatotroph, the mean total somatotroph volume, and the mean number per gland do not change. Flow cytometry studies suggested that somatotrophs from adults have less growth hormone (GH) than somatotrophs from young birds. The increases in total somatotroph volume and number from 5 to 11 weeks are consistent with the rise in anterior pituitary GH reported previously. Basic quantitative morphological information about age-related changes in somatotrophs is reported here. When combined with additional facts from future work, they may explain the well-documented sharp decline in circulating GH from 5 to 11 weeks.

Aging↗
PubMed1997

Chronic administration of growth hormone (GH) to adult chickens exerts marked effects on circulating concentrations of insulin-like growth factor-I (IGF-I), IGF binding proteins, hepatic GH regulated gene I, and hepatic GH receptor mRNA.

In young birds, growth hormone (GH) administration has been found to have only a small or even no effect on circulating concentrations of insulin-like growth factor-I (IGF-I). This is in obvious contrast to the situation in mammals. The present study examines the effect of continuous administration of GH in adult male chickens. Plasma concentrations of IGF-I were markedly elevated (2.5-3.0-fold, p < 0.001) in GH-treated chickens. There were also some transient increases in the circulating levels of IGF binding proteins. Adult chickens showed other manifestations of increased responsiveness to GH, including elevated hepatic expression of GH-regulated gene-I (mRNA) with GH treatment (p < 0.05), and a tendency (p < 0.08) for decreased GH-receptor mRNA. In contrast to the changes in circulating concentrations of GH and IGF-I with GH treatment, no changes in plasma concentrations of thyroid hormones, reproductive hormones, glucose, or nonesterified fatty acids were evident.

Animals↗
PubMed1997

Pulsatile release of somatotropin related to meal feeding and somatotropin response to secretagogues in horses.

Our goal was to establish a time of day and(or) interval from feeding that would avoid the refractory period after a somatotropin (ST) surge and optimize the responsiveness of horses to ST secretagogues. Two experiments were conducted with eight geldings conditioned to consume grain at 0800 and 1600 daily. In Exp. 1, during a 24-h period, these geldings averaged 3.2 +/- .3 pulses of ST with peak amplitude of 4.2 +/- .4 ng/mL, pulse duration of 55 +/- 6 min, and interpeak interval of 400 +/- 57 min. No ST peaks occurred within 2 h after either grain feeding. In Exp. 2, eight geldings were given 50 micrograms of ST-releasing factor (STRF) at 0800. Two geldings that had a pulse of ST between 0700 and 0800 failed to respond to STRF, but the other six responded with a pulse of ST at 37 +/- 3 min; peak amplitude was 4.6 +/- 2.2 ng/mL and duration was 123 +/- 25 min. Experiments 3 and 4 were with mares aged 20 to 26 yr and conditioned to be fed grain at 0800 daily. In Exp. 3, blood was sampled for 8 h beginning at 0500. Seven of the eight mares had a ST pulse in progress at 0500. Five additional pulses were detected, all from 0740 to 0940, but none from 0600 to 0700 or from 1000 to 1300. In Exp. 4, four of the same eight mares were given 50 micrograms of STRF at 0700 and the other four at 1300. Three of the four treated at 0700 and all four treated at 1300 responded to STRF with ST peaks at 20 +/- 5 min; peak amplitude was 12.7 +/- 9.5 ng/mL and duration was 69 +/- 6 min. In Exp. 5, nine mares aged 20 to 26 yr were fed grain at 0800 and 1600 as in Exp. 1 and 2 and given a nonpeptidal ST secretagogue (STS, Merck L-163,255) i.v. at 0, 1, or 5 mg/kg (n = 3 mares/dose) at 1300. No mare had a pulse of ST during the 1 h before treatment. All six mares given STS responded with ST pulses. The ST responses to STS at 1 and 5 mg/kg did not differ (P > .05); time to ST peak was 35 +/- 4 min, pulse amplitude was 24.0 +/- 6.3 ng/mL, and pulse duration was 100 +/- 9 min. We conclude that mares and geldings fed grain once or twice daily usually have a period of 2 to 5 h after feeding with no ST pulses. When horses are fed grain at 0800, one may give a ST secretagogue at 1300 to avoid a refractory period and improve the probability of an ST response.

Aging↗
PubMed1997

Feed intake, body weight, body condition score, musculation, and immunocompetence in aged mares given equine somatotropin.

Sixteen 20- to 26-yr-old mares were given 0, 6.25, or 12.5 mg/d equine somatotropin (eST) to determine whether aged mares respond to ST with changes in feed intake, body weight, body condition score (based mostly on fat cover), or immunocompetence. Neither dry matter intake, body weight, nor body condition scores were altered during the 6 wk of eST injection. However, based on photographs taken to evaluate musculation before and after treatment (scores 0 to 4), mares given eST developed greater (P < .07) muscle definition (1.8 +/- .6 and 2.5 +/- .6 for 6.25 and 12.5 mg eST/d, respectively) than control mares (.7 +/- .4). Total circulating leukocytes increased (P < .05) in both of the eST-treated groups during the 6-wk injection period, caused by an increase (P < .05) in granulocytes. Lymphocyte numbers were not altered. Granulocyte oxidative burst activity was not altered by eST treatment. Although lymphocyte proliferative responses to phytohemagglutinin, pokeweed mitogen, or lipopolysaccharide were not altered during the treatment period, lymphocyte proliferation in response to phytohemagglutinin and pokeweed mitogen increased twofold in eST-treated horses at 2 wk after eST treatment. In overview, the increased musculation and the increase in granulocyte numbers in mares given eST suggest that eST supplementation may improve the health and well-being of aged mares.

Aging↗
PubMed1997

Acute effects of short-term feed deprivation and refeeding on circulating concentrations of metabolites, insulin-like growth factor I, insulin-like growth factor binding proteins, somatotropin, and thyroid hormones in adult geldings.

Two studies were performed with Standardbred geldings 7 to 21 yr of age to determine the sequence of changes in blood plasma concentrations of some hormones and metabolites during feed deprivation for 48 h and for 12 h after refeeding. Plasma hormone and metabolite concentrations were determined with methods validated for horse plasma. Insulin-like growth factor binding proteins (IGFBP) were determined with radioligand analysis following SDS-PAGE electrophoresis. In both experiments, plasma concentrations of triiodothyronine and thyroxine decreased (P < .01) during feed deprivation and increased (P < .01) during refeeding. Plasma glucose and IGF-I either decreased or were not altered during feed deprivation. In contrast, plasma concentrations of NEFA and urea nitrogen increased (P < .01) during feed deprivation and decreased (P < .01) during the refeeding period. Plasma somatotropin (ST) increased (P < .01) approximately 80% at 24 to 36 h of feed deprivation, declined (P < .01) to control values at 48 h of feed deprivation, increased (P < .01) nearly three fold at 3 h after refeeding, and returned to control values by 6 h after refeeding. We identified five IGFBP, and their plasma concentrations were not significantly altered during feed deprivation or following refeeding. We conclude that metabolite availability during feed deprivation and following refeeding alters the secretion of thyroid hormones, ST, and possibly IGF-I, thereby maintaining homeostasis in horses.

Aging↗
PubMed1997

The effects of dietary restriction on insulin-like growth factor (IGF)-I and II, and IGF-binding proteins in chickens.

The effect of feed (energy/protein) restriction on circulating concentrations of insulin-like growth factor (IGF)-I and II, and IGF-binding proteins (IGFBPs) was examined in young (4-week-old) chickens. Increasing levels of feed restriction caused progressive growth retardation, as evidenced by decreased body-weight gain and reduced bone growth. Plasma concentrations of both IGF-I and IGF-II were decreased, and the degree of reduction in the plasma concentrations of these growth factors appeared to be related to the magnitude of feed restriction. A tendency for greater decreases in these growth factors appeared to be associated with greater feed restriction at the majority of time points evaluated. However, nutritional restriction had a greater effect on plasma concentrations of IGF-I than on those of IGF-II. The reductions in plasma concentrations of IGF-I were observed earlier in the experiment and at a lower degree of nutritional deprivation than for plasma concentrations of IGF-II, possibly suggesting greater sensitivity of IGF-I plasma concentrations to feed restriction. Three IGFBPs with molecular weights of 30, 36, and 40 kDa were detected by radioligand assay following separation by SDS-electrophoresis. The 30-kDa IGFBP was most affected by feed restriction with binding activity of this IGFBP increased by 2 days of feed restriction irrespective of the degree of feed deprivation. The binding activity of the 36-kDa IGFBP was increased, albeit transiently, on the second day of feed restriction. Nutritional restriction had no discernible effect on the binding activity of the 40-kDa IGFBP. Increases in the binding activity of the 30-kDa IGFBP appeared to correspond with the observed decreases in IGF-I plasma concentrations. This suggests decreased bioavailability of IGF-I, and possibly IGF-II, attributed to the formation of a complex between IGF-I and the 30-kDa IGFBP during feed restriction. The initial increase in binding activity of the 36-kDa IGFBP may suggest that this binding protein also plays a role in the regulation and availability of circulating concentrations of IGF-I and IGF-II. Although the binding activity of the 40-kDa IGFBP was unaffected by feed restriction, we can not exclude its importance in the regulation of IGF-I. The substantial binding activity of the 40-kDa IGFBP observed in this experiment suggests that it is one of the major chicken IGFBPs, and that its role in IGF-I regulation warrants further study.

Animals↗
PubMed1996

Comparison of the ontogenesis of thyroid hormones, growth hormone, and insulin-like growth factor-I in ad libitum and food-restricted (altricial) European starlings and (precocial) Japanese quail.

In this study, we compare the ontogenic patterns for thyroid hormones, growth hormone (GH), and insulin-like growth factor-I (IGF-I) in altricial European starlings and precocial Japanese quail and examine the effects of feed restriction on these species. The most marked difference in development between the altricial and precocial birds was with respect to plasma thyroid hormone patterns. In the starling, circulating concentrations of triiodothyronine (T3) and thyroxine (T4) were very low in embryos, then increased progressively after hatching to peak at 10-11 days of age. In contrast, in quail, in which other studies have shown that most thyroid maturation occurs during the embryonic and peri-hatch periods, the circulating concentrations of T3 and T4 showed little posthatch ontogenic change. Plasma concentrations of both GH and IGF-I showed similar patterns in both species with a posthatch rise (peak at 3 days in starlings and 8 days in quail), followed by a decline. Food restriction to maintain body weight resulted in decreased plasma concentrations of T3 and IGF-I in both species. After return to ad libitum feeding, plasma T3 and IGF-I increased in both early and late restricted starlings and in late restricted quail. Although both species responded to food restriction with similar patterns of endocrine change, age-related differences in the magnitude of hormonal responses were observed.

Aging↗
PubMed1996

Effect of acid or aluminum on growth and adrenal function in young chickens.

Acid precipitation can have a harmful effect on aquatic birds, due in part to increases in aluminum availability. Young rapidly growing (broiler strain) chickens were used as a model to examine the effects of aluminum and acid on growth and circulating concentrations of adrenocorticol hormones. Two concentrations of acid (sulfuric acid) or aluminum (aluminum sulfate) or sodium sulfate were administered to a heavy (broiler) strain of chickens for 10 days (Days 4 to 14 of age). Additional treatment groups included a control diet either fed ad libitum or pair-fed relative to the chicks on the acid or aluminum diets. Compared with the chicks receiving the control diet ad libitum, growth (body weight) was reduced in chicks on the aluminum (high and low level), acid (high level), and sodium sulfate (high level) treatments and the respective pair-fed groups. Circulating concentrations of corticosterone (B) were elevated in the chicks receiving the high dose of aluminum and the respective pair-fed control when compared with the chicks which had free access to the control diet. Thus, the increase in plasma B appears to be linked to the low food intake and not to the A1 per se. Circulating concentrations of aldosterone were increased in the chicks receiving either the high dose of aluminum or the acid relative to chicks fed the control diet (both ad libitum or pair-fed controls). However, circulating concentrations of aldosterone were unaffected by either dose of sodium sulfate employed. Thus, the increase in plasma aldosterone appears to be specific to the metabolic acidosis created by A1 or acid. It is concluded that environmental acid may either directly or indirectly influence adrenocortical function. Moreover, the present study provides evidence for the independent control of circulating concentrations of corticosterone and aldosterone in the chicken.

Acidosis↗
PubMed1996

Age and breed differences in thyroid hormones, insulin-like growth factor (IGF)-I and IGF binding proteins in female horses.

A survey with horses was conducted to determine whether plasma concentrations of triiodothyronine (T3), thyroxine (T4), insulin-like growth factor (IGF)-I and IGF binding proteins (IGFBP) change as horses grow, mature sexually, and age. Jugular blood was sampled from Standardbred fillies and mares at ages 0, 1, 7, and 14 d, at 1, 2, 4, 5, 6, and 9 mo, and at 5 to 8 and 16 to 22 yr (n = 5 to 18). In a second survey, we measured the same variables in eight breeds of horses with markedly different adult body sizes, from Miniatures to Friesians. Plasma T3, T4, and IGF-I were determined by radioimmunoassays validated for horses, and IGFBP were estimated from radioligand assay following separation of the IGFBP by SDS-PAGE electrophoresis. Plasma T3 decreased (P < .01) nearly continuously from 7.9 ng/mL on the day of birth to .9 ng/mL at 6 mo, and then changed little from .7 ng/mL at 9 mo to .5 ng/mL in mares 16 to 22 yr old. Similarly, T4 declined (P < .01) from 233 ng/mL on the day of birth to 49 ng/mL at 14 d and varied from 35 to 9 ng/mL among all of the older age groups. Plasma concentrations of IGF-I increased (P < .01) from 285 ng/mL on the day of birth to 572 ng/mL at 14 d, remained relatively constant until 9 mo of age (530 ng/mL), and then declined (P < .01) to low levels (295 ng/mL) in the oldest mares. We detected six IGFBP. The two smallest IGFBP (26 and 39 kDa) were highest during the first 14 d after birth and lowest (P < .01) in aged mares. The four larger IGFBP were lowest at birth and increased to the highest values during the most rapid growth period, but these changes were not significant (P > .20). In agreement with data for other species, our data suggest that IGF-I and IGFBP modulate growth in horses. Although there were impressive interbreed differences in circulating concentrations of T3, T4, IGF-I, and IGFBP, these were not related to differences in adult body size.

Aging↗
PubMed1996

The suppressive effects of testosterone on growth in young chickens appears to be mediated via a peripheral androgen receptor; studies of the anti-androgen ICI 176,334.

ICI 176,334 is a nonsteroidal anti-androgen that has been shown to selectively block peripheral androgen receptors in rats and is presumed to do so in chickens. In chickens, androgens stimulate secondary sexual characteristics (e.g., comb), but inhibit growth and the immune tissues. The present study examined the effect of dietary ICI 176,334 (5 or 25 mg/kg body weight) on growth in chickens in the presence or absence of testosterone treatment (as 1-cm long silastic implants). Treatments began at 2 wk of age and continued through 6 wk of age. Testosterone alone reduced body growth (average daily gain and shank-toe length, together with weights of the body, skeletal muscle, and the bursa of Fabricius, an immune tissue), and stimulated comb development. At the low dose (5 mg/kg), ICI 176,334 alone had no effect on body growth or organ weight with the exception that comb weight was reduced. At the high dose (25 mg/kg), ICI 176,334 decreased growth (body weight, average daily gain, and shank-toe length) and organ weights (breast muscle, bursa of Fabricius, testis, and comb weights). This effect may represent a toxicity. As might be expected with an anti-androgen, ICI 176,334 (at either 5 or 25 mg/kg) completely suppressed the stimulation of comb growth evoked by testosterone. Similarly, ICI 176,334 (5 mg/kg) overcame, albeit partially, the growth-suppressive effects of testosterone (on body weight, average daily gain, shank-toe length, and breast muscle weight) and also had inhibitory effects on the weights of the testis and bursa of Fabricius. The anti-androgen, ICI 176,334, did not influence the reduction in circulating concentrations of luteinizing hormone occurring after testosterone treatment. The present data are consistent with the growth-suppressive effects of testosterone in chickens being mediated via a peripheral androgen receptor. No effects of either testosterone or ICI 176,334 were observed on circulating concentrations of insulin-like growth factor-I despite the marked changes in growth rate.

Androgen Antagonists↗
PubMed1996

Differential and tissue-specific regulation of (pro)insulin and insulin-like growth factor-I mRNAs and levels of thyroid hormones in growth-retarded embryos.

The control of embryonic growth in vertebrates appears to rely on the orchestrated action of several families of growth factors and hormones. The contribution of insulin-like growth factor (IGF-I) to prenatal growth regulation is better established in mammals than in other vertebrate species. The status of (pro)insulin gene product(s) in the pancreas and non-pancreatic tissues may be another important contribution to embryonic growth signals. We have characterized tissue sources of IGF-I gene and (pro)insulin gene mRNAs in normal chicken embryogenesis and their changes in a model of avian growth retardation. We studied, by a highly sensitive reverse-transcription coupled to polymerase chain reaction (RT-PCR), the expression of IGF-I and (pro)insulin genes in brain, pancreas, liver and eye in embryos from late organogenesis (E8) to late development (E17); hatching is at E20-21, a period of fast embryonic growth. In brain, pancreas and eye, growth-retarded embryos had lower IGF-I mRNA expression. In contrast, in the liver, little IGF-I mRNA was found during normal embryogenesis, but some early induction occurred in E17 growth-retarded embryos. (pro)insulin gene expression was much lower in absolute levels in non-pancreatic tissues than in pancreas. However, it was developmentally regulated in brain, liver and eye. The growth-retarded, IGF-I-deficient embryos had an increased expression of (pro)insulin mRNA in the brain. While IGF-I treatment of growth-retarded embryos increased their serum IGF-I values, only partial recovery of embryonic weight was obtained. Since abnormalities in other hormones may contribute to the failure of systemic IGF-I to reverse the retarded phenotype, thyroid hormones (T3 and T4) levels were determined in liver, brain and eye. They were markedly altered only in the liver of growth-retarded embryos, where an increase in thyroid hormone content was observed. We conclude that, in chicken embryos and possibly other vertebrates, normal growth may implicate multiple hormones, including the concerted action, endocrine/paracrine, of IGF-I and (pro)insulin gene products.

Animals↗
PubMed1995

Evidence for functionally distinct subpopulations of steroidogenic cells in the domestic turkey (Meleagris gallopavo) adrenal gland.

A body of histological and functional evidence supports the hypothesis that there are functionally distinct subpopulations of steroidogenic cells comprising the avian adrenal gland. In the present study, we tested this hypothesis by evaluating the steroidogenic responses of density-dependent subpopulations of adrenal steroidogenic cells isolated from domestic turkeys fed either a high-normal (control) sodium diet (0.4% Na+) or a Na(+)-restricted diet (0.04% Na+) for 8 days, the latter to stimulate the activity or appearance of possible zona glomerulosa-like cells. Subpopulations were visually yet reproducibly determined by their density-dependent separation on a continuous density gradient of Percoll (45%). The subpopulations were arbitrarily ascribed as being either low-density or high-density adrenal steroidogenic cells [LDAC (p = 1.0350-1.0585 g/ml) and HDAC (p = 1.0590-1.0720 g/ml), respectively]. LDAC and HDAC comprised 95.2 and 4.8%, respectively, of the total number of adrenal steroidogenic cells isolated. The LDAC was further subdivided into three visually distinct subpopulations. The functional differences between the LDAC subpopulations is discussed but was less dramatic than the functional distinction between the HDAC subpopulation and the pooled LDAC subpopulations. Basal aldosterone production values between control LDAC and HDAC were equivalent. In addition, there were no differences in maximal aldosterone production between control LDAC and HDAC in response to [Ile5]angiotensin II (AII), the avian equivalent, [Val5]AII, K+ (as KCl), and that supported by exogenous corticosterone. However, maximal aldosterone production in response to human ACTH-(1-39) (ACTH) of the LDAC was 32% greater than that of the HDAC. Na+ restriction enhanced basal aldosterone production of the LDAC by 84% over the control LDAC. In addition, it enhanced maximal aldosterone production of the LDAC in response to AII peptides, K+, ACTH and that supported by corticosterone by 54, 164, 83, and 74%, respectively, over that of the control LDAC. However, Na+ restriction disproportionately enhanced basal aldosterone production of the HDAC by 348% over that of the control HDAC. In addition, with Na+ restriction, maximal aldosterone production of the HDAC in response to AII, K+, and ACTH and that supported by exogenous corticosterone was consistently greater than that of the LDAC. Moreover, with Na+ restriction, maximal aldosterone production of the HDAC in response to AII peptides and K+ was increased over that of the control HDAC to a greater extent than was maximal aldosterone production in response to ACTH and that supported by corticosterone (% enhancement over control was as follows: AII peptides, 502%; K+, 668%; ACTH, 273%; corticosterone, 183%).(ABSTRACT TRUNCATED AT 400 WORDS)

Adrenal Glands↗
PubMed1995

Effect of dietary acid or aluminum on growth and growth-related hormones in young chickens.

The effect of two concentrations of dietary acid (sulfuric acid) or aluminum (aluminum sulfate) on growth and growth-related hormones was examined in a heavy (broiler) strain of chicken between 4 and 18 days old. Growth (body weight, average daily gain, and tibial length) in chicks receiving either dietary acid or aluminum-containing diets were compared to chicks fed a control diet and to chicks fed diets containing sodium sulfate. Despite the reduced growth in acid-fed chicks, there were no changes in the plasma concentrations of growth hormone, insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding proteins (IGF-BP). However, in chicks receiving the high aluminum diet where growth was markedly depressed (by 57%), plasma concentrations of IGF-I were depressed, while those of the 36-kDa IGF-BP were elevated. The effects of acid and aluminum on growth were mediated at least partially by reductions in feed intake. Pair feeding depressed growth and tended to decrease plasma concentrations of IGF-I. Some differences were observed between acid or aluminum groups and their respective pair-fed controls. For the groups receiving the low-aluminum and both the high- and low-acid diets, values were increased compared to corresponding pair-fed controls for average daily gain, the level of the 36-kDa IGF-BP, and skeletal growth. On the other hand, high aluminum had a toxic effect in addition to reducing feed intake, with skeletal growth being reduced more in chicks receiving the aluminum diet than in the pair-fed controls.

Aluminum↗
PubMed1995

Angiogenic activity of anterior pituitary tissue and growth hormone on the chick embryo chorio-allantoic membrane: a novel action of GH.

A useful system to evaluate the angiogenic activity of hormones and growth factors is the chorioallantoic membrane (CAM) of chick embryos. The present studies examined the angiogenic activity of chicken anterior pituitary glands and both fibroblast growth factor (FGF) and growth hormone (GH). Grafts of anterior pituitary gland evoked an angiogenic response on the CAM which was lost if the adenohypophyseal tissue was first boiled. The magnitude of the angiogenic response to anterior pituitary glands increased with the age of the donor (from a minimum 15 days of embryonic development to a maximum between 2 and 6 weeks old). In view of the similarity of the profile of the angiogenic response and the reported changes in GH secretion, the angiogenic activity of GH was then examined. Considerable angiogenic responses were observed with GH; there being increases (P < 0.05) in number of new blood vessels on the CAM of chick embryos on which native chicken GH or native bovine GH or recombinant bovine GH were added. These data support GH having an angiogenic action.

Allantois↗
PubMed1994

Kinetic parameters of plasma thyroid hormone and thyroid hormone receptors in a dwarf and control line of chicken.

Sex-linked dwarf chickens have in plasma low triiodothyronine (T3) levels and slightly raised thyroxine (T4) concentrations and are functional hypothyroid. The kinetic parameters of T4 and T3 were investigated using 125I-labeled hormones. In addition the nuclear T3-receptors in the liver were examined using a radioreceptorassay and Scatchard analysis. Four-week-old dwarf (dw) and normal (Dw) chickens were injected with 125I-labeled T3 or T4 and blood samples taken 60, 120, 180, and 300 min after 125I-T3 injection and 120, 240, 360, and 480 minutes after 125I-T4 treatment. Labeled T4 and T3 and the degradation products were separated by paper chromatography. After the paper strips were dried, the iodinated compounds were visualized and counted in the gamma counter. The kinetic parameters, the half-life time (T1/2), the apparent distribution volume (Vd) and the metabolic clearance rate (MCR) were calculated using the natural base logarithm values of the measured radioactivity plotted against time and used for linear regression. T4 was cleared from circulation more slowly in dwarf than in control chicks and reflected a longer T1/2 (21.8%) and a reduced MCR (45%). The Vd tended to be lower (34.7%) in dwarfs. While the T1/2 of T3 was longer (28.1%) in dwarf chickens than in control animals, the MCR for T3 was considerably increased (31.8%). This results from an increased Vd (63.1%) in the dwarf chicks. The T3-receptor study in the liver of dwarf and non-dwarf chickens from Week 1 to Week 4 posthatching revealed that the total capacity and the affinity constant of the binding sites were comparable in dwarf and normal chickens. However, the occupancy of the receptors was higher in the dwarf animals.

Animals↗